$NVAX news
The latest NVAX stock news: headlines, filings, AI summaries and sentiment for $NVAX, updated around the clock.
- Novavax Reports Q3 2026 Revenue of $68.3 Million and Raises Annual Guidance
- Novavax Outlines $400 Million Revenue Framework for 2026 and Targets Cash Runway Through 2029
- Novavax Raises Full-Year Revenue Guidance Following Q3 Earnings Beat
- NOVAVAX INC - 10-Q Filing
- NOVAVAX INC - 8-K Filing
- Novavax Scheduled to Report Q3 2026 Earnings on November 5
- NOVAVAX INC - 8-K Filing
- Healthcare Sector News Highlights Novavax, Moderna, and Becton Dickinson
- Stocks Making Significant Moves Midday: Marvell, Moderna, Lamb Weston and Others
- Novavax, Moderna trade flat as WHO downplays Russia's plague death
- Moderna's Stock Rises on Strong Momentum from Cancer Vaccine Data
- Novavax receives global approvals for updated Nuvaxovid COVID-19 vaccine
- Moderna Shares Surge on Positive Cancer Vaccine Trial Data
- Moderna Surges 94% in 2026 Amid Leadership Restructuring and Upcoming Product Launches
- Biotech Stocks Rally Amid Hantavirus Concerns
- Pharma Stocks Rise Amid Hantavirus Outbreak
- Novavax Q3 2025 Earnings Report Shows Strategic Shift and Revenue Decline
- Novavax Reports Q1 2026 Earnings with Revenue Drop and Strategic Updates
- Novavax Reports Q2 2025 Earnings with Revenue Drop and Milestone Payment from Sanofi